Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802438 · ClinicalTrials.gov registry record · NA
Eosinophilic Airway Inflammation and Mepolizumab
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00802438 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 38 participants.
The verdict
NCT00802438, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
A drug (mepolizumab) that reduces allergic inflammation will affect the function of allergy cells called eosinophils which are produced by the body in response to allergen exposure.
Interventions
- BIOLOGICAL mepolizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-06-01 |
| Est. Completion | 2013-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00802438
The ClinicalTrials.gov registry entry for NCT00802438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mepolizumab is the first listed.
NCT00802438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00802438 about?
NCT00802438 is a clinical study titled "Eosinophilic Airway Inflammation and Mepolizumab". A drug (mepolizumab) that reduces allergic inflammation will affect the function of allergy cells called eosinophils which are produced by the body in response to allergen exposure.
What is the current status of trial NCT00802438?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2008-06-01. Estimated completion is 2013-03-01.
What interventions are being tested in trial NCT00802438?
The interventions under investigation include: mepolizumab (BIOLOGICAL).
Who is sponsoring clinical trial NCT00802438?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.